Brera Holdings PLC Class B Ordinary Shares (BREA) had the highest return between September 30, 2022 and May 12, 2023 by a US stock, returning 4,779,900%.
| ASSET | DATE | % RETURN |
|---|---|---|
Brera Holdings PLC Class B Ordinary Shares (BREA) | 9/30/2022 - 5/12/2023 | 4,779,900% |
NioCorp Developments Ltd Common Stock (NB) | 9/30/2022 - 5/12/2023 | 549,900% |
SS Innovations International Inc Common Stock (SSII) | 9/30/2022 - 5/12/2023 | 18,309.09% |
Castellum (CTM) | 9/30/2022 - 5/12/2023 | 8,650% |
Foremost Lithium Resource & Technology Ltd Common stock (FMST) | 9/30/2022 - 5/12/2023 | 3,035.14% |
Cabaletta Bio (CABA) | 9/30/2022 - 5/12/2023 | 1,774.06% |
Scilex (SCLXW) | 9/30/2022 - 5/12/2023 | 752.94% |
Reviva Pharmaceuticals (RVPHW) | 9/30/2022 - 5/12/2023 | 752.17% |
Viking Therapeutics (VKTX) | 9/30/2022 - 5/12/2023 | 725.27% |
Cns Pharmaceuticals (CNSP) | 9/30/2022 - 5/12/2023 | 670.95% |
Ucloudlink (UCL) | 9/30/2022 - 5/12/2023 | 599.63% |
American Coastal Insurance (ACIC) | 9/30/2022 - 5/12/2023 | 558.54% |
Banzai International (BNZIW) | 9/30/2022 - 5/12/2023 | 485.38% |
TG Therapeutics (TGTX) | 9/30/2022 - 5/12/2023 | 420.03% |
Synergy CHC Corp Common Stock (SNYR) | 9/30/2022 - 5/12/2023 | 390.12% |
Ohmyhome Limited Ordinary Shares (OMH) | 9/30/2022 - 5/12/2023 | 385.79% |
Madrigal Pharmaceuticals (MDGL) | 9/30/2022 - 5/12/2023 | 370.4% |
Reviva Pharmaceuticals (RVPH) | 9/30/2022 - 5/12/2023 | 358.75% |
Pulse Biosciences (PLSE) | 9/30/2022 - 5/12/2023 | 346.96% |
ENDRA Life Sciences (NDRA) | 9/30/2022 - 5/12/2023 | 337.5% |
Genelux Corporation Common Stock (GNLX) | 9/30/2022 - 5/12/2023 | 325% |
US GoldMining Inc Warrant (USGOW) | 9/30/2022 - 5/12/2023 | 298.18% |
Biomotion Sciences Warrant (SLXNW) | 9/30/2022 - 5/12/2023 | 295.44% |
Ardelyx (ARDX) | 9/30/2022 - 5/12/2023 | 273.04% |
So-Young International (SY) | 9/30/2022 - 5/12/2023 | 268.86% |
